Paget’s Disease of Bone

  • Zoledronate in the prevention of Paget’s (ZiPP): protocol for a randomised trial of genetic testing and targeted zoledronic acid therapy to prevent SQSTM1-mediated Paget’s disease of bone
    Owen Cronin, Laura Forsyth, Kirsteen Goodman, Steff C Lewis, Catriona Keerie, Allan Walker, Mary Porteous, Roseanne Cetnarskyj, Lakshminarayan R Ranganath, Peter L Selby, Geeta Hampson, Rama Chandra, Shu Ho, Jon H Tobias, Steven Young-Min, Malachi J McKenna, Rachel K Crowley, William D Fraser, Luigi Gennari, Ranuccio Nuti, Maria Luisa Brandi, Javier Del Pino-Montes, Jean-Pierre Devogelaer, Anne Durnez, Giancarlo Isaia, Marco Di Stefano, Núria Guañabens, Josep Blanch, Markus J Seibel, John P Walsh, Mark A Kotowicz, Geoffrey C Nicholson, Emma L Duncan, Gabor Major, Anne Horne, Nigel L Gilchrist, Maarten Boers, Gordon D Murray, Keith Charnock, Diana Wilkinson, R Graham G Russell, Stuart H Ralston